Acute Instruments Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 0.49%
- Profit Growth 13.29%
- Ebitda -38.24%
- Net Worth 72.89%
- Total Assets 29.99%
About Acute Instruments
Acute Instruments Private Limited (AIPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 September 2011 and has a history of 13 years and four months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rekha Pawar and Sakshi Pawar serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U29253MH2011PTC221922
-
Company No.
221922
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Sep 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Acute Instruments Private Limited offer?
Acute Instruments Private Limited offers a wide range of products and services, including Analyzers & Analytical Instruments, Spectrometer, Chemical Plants & Machinery, Distillation Units, Laboratory & Lab Equipment, Laboratory Apparatus, Testing & Measuring Equipments, Oil Testing Kit.
Who are the key members and board of directors at Acute Instruments?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rekha Pawar
|
Director | 16-Oct-2012 | Current |
|
Sakshi Pawar
|
Director | 23-Mar-2022 | Current |
Financial Performance of Acute Instruments.
Acute Instruments Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 0.49% increase. The company also saw a substantial improvement in profitability, with a 13.29% increase in profit. The company's net worth Soared by an impressive increase of 72.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acute Instruments?
In 2020, Acute Instruments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Acute Instruments?
Acute Instruments has a workforce of 10 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acute Instruments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acute Instruments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
